These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 36359297)

  • 1. Exploiting DNA Replication Stress as a Therapeutic Strategy for Breast Cancer.
    Zhang J; Chan DW; Lin SY
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36359297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting replicative stress in gynecological cancers as a therapeutic strategy.
    Ngoi NY; Sundararajan V; Tan DS
    Int J Gynecol Cancer; 2020 Aug; 30(8):1224-1238. PubMed ID: 32571890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploiting DNA Replication Stress for Cancer Treatment.
    Ubhi T; Brown GW
    Cancer Res; 2019 Apr; 79(8):1730-1739. PubMed ID: 30967400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting DNA repair, DNA metabolism and replication stress as anti-cancer strategies.
    Puigvert JC; Sanjiv K; Helleday T
    FEBS J; 2016 Jan; 283(2):232-45. PubMed ID: 26507796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting radioresistant breast cancer cells by single agent CHK1 inhibitor via enhancing replication stress.
    Zhang Y; Lai J; Du Z; Gao J; Yang S; Gorityala S; Xiong X; Deng O; Ma Z; Yan C; Susana G; Xu Y; Zhang J
    Oncotarget; 2016 Jun; 7(23):34688-702. PubMed ID: 27167194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Targeting of DNA Replication Stress in Cancer.
    Gu L; Hickey RJ; Malkas LH
    Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting DNA Replication Stress for Cancer Therapy.
    Zhang J; Dai Q; Park D; Deng X
    Genes (Basel); 2016 Aug; 7(8):. PubMed ID: 27548226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting DNA Replication Stress and DNA Double-Strand Break Repair for Optimizing SCLC Treatment.
    Bian X; Lin W
    Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31480716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging strategies for cancer therapy by ATR inhibitors.
    Yano K; Shiotani B
    Cancer Sci; 2023 Jul; 114(7):2709-2721. PubMed ID: 37189251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic RAS sensitizes cells to drug-induced replication stress via transcriptional silencing of P53.
    Segeren HA; van Liere EA; Riemers FM; de Bruin A; Westendorp B
    Oncogene; 2022 May; 41(19):2719-2733. PubMed ID: 35393546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target Actionability Review: a systematic evaluation of replication stress as a therapeutic target for paediatric solid malignancies.
    Keller KM; Krausert S; Gopisetty A; Luedtke D; Koster J; Schubert NA; Rodríguez A; van Hooff SR; Stichel D; Dolman MEM; Vassal G; Pfister SM; Caron HN; Stancato LF; Molenaar JJ; Jäger N; Kool M
    Eur J Cancer; 2022 Feb; 162():107-117. PubMed ID: 34963094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of DNA2 nuclease as a therapeutic strategy targeting replication stress in cancer cells.
    Kumar S; Peng X; Daley J; Yang L; Shen J; Nguyen N; Bae G; Niu H; Peng Y; Hsieh HJ; Wang L; Rao C; Stephan CC; Sung P; Ira G; Peng G
    Oncogenesis; 2017 Apr; 6(4):e319. PubMed ID: 28414320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Completing genome replication outside of S phase.
    Bhowmick R; Hickson ID; Liu Y
    Mol Cell; 2023 Oct; 83(20):3596-3607. PubMed ID: 37716351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MCM10 compensates for Myc-induced DNA replication stress in breast cancer stem-like cells.
    Murayama T; Takeuchi Y; Yamawaki K; Natsume T; Li M; Marcela RN; Nishimura T; Kogure Y; Nakata A; Tominaga K; Sasahara A; Yano M; Ishikawa S; Ohta T; Ikeda K; Horie-Inoue K; Inoue S; Seki M; Suzuki Y; Sugano S; Enomoto T; Tanabe M; Tada KI; Kanemaki MT; Okamoto K; Tojo A; Gotoh N
    Cancer Sci; 2021 Mar; 112(3):1209-1224. PubMed ID: 33340428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms used by cancer cells to tolerate drug-induced replication stress.
    Segeren HA; Westendorp B
    Cancer Lett; 2022 Sep; 544():215804. PubMed ID: 35750276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of replication fork speed: Mechanisms and impact on genomic stability.
    Merchut-Maya JM; Bartek J; Maya-Mendoza A
    DNA Repair (Amst); 2019 Sep; 81():102654. PubMed ID: 31320249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA replication stress: from molecular mechanisms to human disease.
    Muñoz S; Méndez J
    Chromosoma; 2017 Feb; 126(1):1-15. PubMed ID: 26797216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the replication stress response through synthetic lethal strategies in cancer medicine.
    Ngoi NYL; Pham MM; Tan DSP; Yap TA
    Trends Cancer; 2021 Oct; 7(10):930-957. PubMed ID: 34215565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting ATR as Cancer Therapy: A new era for synthetic lethality and synergistic combinations?
    Bradbury A; Hall S; Curtin N; Drew Y
    Pharmacol Ther; 2020 Mar; 207():107450. PubMed ID: 31836456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Y-family translesion DNA polymerases in replication stress: Implications for new cancer therapeutic targets.
    Tonzi P; Huang TT
    DNA Repair (Amst); 2019 Jun; 78():20-26. PubMed ID: 30954011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.